4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-030300
President and CEO sold 18,333 shares at an average $58.64 ($1,075,102)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2021-05-03 | Sale | −13,997 | $58.45 | $818,083 | 2,233,411 | I |
| Watts Ryan J. President and CEO | 2021-05-03 | Sale | −3,485 | $59.12 | $206,030 | 2,229,926 | I |
| Watts Ryan J. President and CEO | 2021-05-03 | Sale | −851 | $59.92 | $50,989 | 2,229,075 | I |
| Open-market sales · 18,333 sh · avg $58.64 · $1,075,102 | |||||||
Loading xslF345X03/doc4.xml…